Hyperfibrinolysis in Cats: A Retrospective Case–Control Study of 154 Cats
Journal of Veterinary Internal Medicine · 2025
DOI: 10.1111/jvim.70201 ↗At a glance
Journal article in Journal of Veterinary Internal Medicine, 2025. Written by Anabel Priego-Corredor and 4 co-authors. Institution: Veterinary Teaching Hospital of the Catholic University of Valencia (VTHCUV), Valencia, Spain. Major MEDLINE topics: Cat Diseases, Fibrinolysis, Blood Coagulation Disorders. Cited 1 times so far (Crossref); 80 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Background
Hyperfibrinolysis (HFL) has not been well described in cats. Hypothesis/Objectives Identify risk factors associated with HFL in cats and evaluate its association with survival. Our hypotheses were that cats share similar conditions as dogs and humans with HFL and that it is associated with a worse prognosis. Animals A total of 154 client-owned cats had thromboelastography (TEG) performed because of a variety of clinical conditions.
Methods
Retrospective case–control study. Cases were defined as cats with HFL (clot lysis at 30 min [LY30] ≥ 5% or clot lysis at 60 min [LY60] ≥ 10% or both) and controls were cats that had TEG performed but without HFL. Signalment, conditions that may alter fibrinolysis, TEG variables, indications to perform TEG, and outcome were recorded.
Results
Fifty-two cats (33.8%) with HFL and 102 controls (66.2%) were included. Demographic variables were similar between groups. Both liver disease (odds ratio [OR], 5.0; 95% confidence interval [CI], 2.4–10.6; p < 0.001) and the presence of cavitary effusion (OR, 5.9; 95% CI, 2.8–12.4; p < 0.001) were important risk factors for HFL. Cats with heart disease were less likely to have HFL (OR, 0.2; 95% CI, 0.1–0.5; p < 0.001). The presence of HFL was not associated with worse outcome (p = 0.84). Cats with HFL more often were hypocoagulable, whereas cats without HFL more often were hypercoagulable (p < 0.001). Conclusions and Clinical Importance Liver disease and cavitary effusion are risk factors for HFL in cats. The presence of HFL did not affect survival.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Veterinary Teaching Hospital of the Catholic University of Valencia (VTHCUV), Valencia, Spain.
- AniCura Valencia Sur Veterinary Hospital, Internal Medicine, Silla, Spain.
ORCID profiles: Anabel Priego-Corredor
Cite
APA
Priego-Corredor, A., Del Saiz-Álvarez, M. R., Vila-Soriano, A., Castro-López, J., & Herrería-Bustillo, V. (2025). Hyperfibrinolysis in Cats: A Retrospective Case–Control Study of 154 Cats. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.70201
Vancouver
Priego-Corredor A, Del Saiz-Álvarez MR, Vila-Soriano A, Castro-López J, Herrería-Bustillo V. Hyperfibrinolysis in Cats: A Retrospective Case–Control Study of 154 Cats. Journal of Veterinary Internal Medicine. 2025. doi:10.1111/jvim.70201
BibTeX
@article{PriegoCorredor2025,
author = {Priego-Corredor, Anabel and Del Saiz-Álvarez, María Rocío and Vila-Soriano, Anna and Castro-López, Jorge and Herrería-Bustillo, Vicente},
title = {Hyperfibrinolysis in Cats: A Retrospective Case–Control Study of 154 Cats},
journal = {Journal of Veterinary Internal Medicine},
year = {2025},
doi = {10.1111/jvim.70201}
}
EUVIMED